Variables | Categories | Frequency | Percentage |
---|---|---|---|
WHO clinical stages | Stage I | 294 | 74.2 |
Stage II | 59 | 14.9 | |
Stage III | 35 | 8.8 | |
Stage IV | 8 | 2.0 | |
Recent CD4 count | ≤ 200 cells/mm3 | 177 | 44.7 |
>  200 cells/mm3 | 219 | 55.3 | |
Follow up duration | ≤ 10 years | 124 | 31.3 |
>  10 years | 272 | 68.7 | |
Co-morbid medical illness | No | 255 | 64.4 |
Yes | 141 | 35.6 | |
ART regimen | First line | 296 | 74.7 |
Second line | 100 | 25.3 | |
Social support level | Poor | 164 | 41.4 |
Moderate | 184 | 46.5 | |
Strong | 48 | 12.1 | |
Depression | No | 192 | 48.5 |
Yes | 204 | 51.5 | |
Anxiety | No | 287 | 72.5 |
Yes | 109 | 27.5 | |
Perceived stigma | No | 202 | 51.0 |
Yes | 194 | 49.0 | |
Sleep quality | Good | 220 | 55.6% |
Poor | 176 | 44.4 |